Susquehanna International Group’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.06M Buy
960,400
+683,700
+247% +$3.06M 0.01% 4628
2025
Q4
$1.04M Buy
276,700
+216,400
+359% +$421K ﹤0.01% 7090
2025
Q3
$97.1K Buy
60,300
+34,000
+129% +$60.6K ﹤0.01% 11582
2025
Q2
$57.6K Buy
+26,300
New +$40.4K ﹤0.01% 12071
2025
Q1
Sell
-21,000
Closed -$21.8K 13474
2024
Q4
$21.8K Buy
+21,000
New +$24K ﹤0.01% 11900
2024
Q3
Sell
-44,600
Closed -$53.1K 13136
2024
Q2
$53.1K Buy
44,600
+21,500
+93% +$29.3K ﹤0.01% 11389
2024
Q1
$23.3K Sell
23,100
-7,300
-24% -$6.13K ﹤0.01% 11784
2023
Q4
$32.2K Buy
+30,400
New +$32.9K ﹤0.01% 11861
2023
Q2
Sell
-10,600
Closed -$15.2K 13201
2023
Q1
$15.2K Sell
10,600
-800
-7% -$1.98K ﹤0.01% 12116
2022
Q4
$26.9K Sell
11,400
-13,400
-54% -$37.6K ﹤0.01% 11656
2022
Q3
$50K Sell
24,800
-6,200
-20% -$17.1K ﹤0.01% 12206
2022
Q2
$69K Sell
31,000
-86,600
-74% -$254K ﹤0.01% 11778
2022
Q1
$786K Buy
117,600
+10,500
+10% +$61.4K ﹤0.01% 7767
2021
Q4
$592K Sell
107,100
-4,200
-4% -$31.8K ﹤0.01% 8727
2021
Q3
$1.02M Buy
111,300
+25,400
+30% +$236K ﹤0.01% 7514
2021
Q2
$953K Buy
85,900
+29,100
+51% +$284K ﹤0.01% 7910
2021
Q1
$485K Buy
+56,800
New +$465K ﹤0.01% 9542
2018
Q1
Sell
-16
Closed -$6K 10526
2017
Q4
$6K Sell
16
-1
-6% -$484 ﹤0.01% 9127
2017
Q3
$9K Buy
17
+3
+21% +$1.98K ﹤0.01% 8689
2017
Q2
$12K Sell
14
-42
-75% -$36.5K ﹤0.01% 9064
2017
Q1
$51K Sell
56
-109
-66% -$180K ﹤0.01% 8588
2016
Q4
$479K Buy
+165
New +$959K ﹤0.01% 7084

Other funds holding SLS